SCHEMBL4811328

SCHEMBL4811328

CCOC(=O)C1(Cc2ccc(C)cc2)CCCC1OC(=O)c1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
CDC25B P30305 1/20 0.42
POLB P06746 3/20 0.40
KDM4E B2RXH2 2/20 0.39
ADAM17 P78536 1/20 0.39
SCN1A P35498 1/20 0.39
SCN2A Q99250 1/20 0.39
SCN3A Q9NY46 1/20 0.39
KMT2A Q03164 5/20 0.36
MEN1 O00255 4/20 0.36
MAPT P10636 2/20 0.36
ATM Q13315 1/20 0.36
OPRM1 P35372 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4812190 0.95 ADAM17 (0.44) PTPN2PTPN1CDC25BPOLBKDM4E
SCHEMBL4811204 0.95 KDM4E (0.46) PTPN2PTPN1CDC25BPOLBKDM4E
SCHEMBL4811198 0.91 TDP1 (0.41) PTPN2PTPN1CDC25BPOLBADAM17
SCHEMBL4813296 0.90 ADRB2 (0.38) PTPN2PTPN1CDC25BPOLBSCN1A
SCHEMBL4810961 0.90 TP53 (0.39) PTPN2PTPN1CDC25BPOLBKDM4E
SCHEMBL4811180 0.90 PTPN2 (0.42) PTPN2PTPN1CDC25BSCN1ASCN2A
SCHEMBL4807371 0.89 KDM4E (0.46) PTPN2PTPN1CDC25BPOLBKDM4E
SCHEMBL4809649 0.88 POLB (0.41) POLBKDM4EADAM17KMT2AMEN1
SCHEMBL4806741 0.87 PTPN2 (0.41) PTPN2PTPN1CDC25BSCN1ASCN2A
SCHEMBL4809403 0.86 KDM4E (0.40) POLBKDM4EADAM17KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388103-B2 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-06-17 US disclosed
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 US disclosed
WO-2006045246-A1 CYCLOPENTANE CARBOXYLATE COMPOUNDS, PROCESS AND INTERMEDIATES FOR PREPARING THE SAME AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof C5, C1S, AKR1C3 PTPN2 3885/4885PTPN1 3877/4885CDC25B 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.